EVIAN Study

  • Research type

    Research Study

  • Full title

    Early Vitrectomy and Intravitreal Antibiotics for post-operative exogenous eNdophthalmitis: A feasibility multicentre randomised controlled trial (EVIAN Study)

  • IRAS ID

    282733

  • Contact name

    Mahiul MK Muqit

  • Contact email

    Mahi.Muqit1@nhs.net

  • Sponsor organisation

    Moorfields Eye Hospital NHS Foundation Trust

  • Clinicaltrials.gov Identifier

    NCT04522661

  • Duration of Study in the UK

    3 years, 0 months, 1 days

  • Research summary

    What is this study about?
    To assess the feasibility of doing a trial of the benefit of prompt surgery for a rare but blinding bacterial eye infection known as “endophthalmitis” that can complicate any invasive eye procedure. Endophthalmitis causes rapid loss of vision and antibiotic injections into the eye ("intravitreal") may not be sufficient to control the infection. 50% patients need surgery to remove the infected vitreous (vitrectomy) with patients requiring intensive and extended inpatient/outpatient management over a 6-month period. The impact on the well being of patients and their carers, both physically and psychologically, is immense often with severe pain and sight loss, which may or may not recover.

    How will this study help patients?
    Earlier surgery, by removing infected vitreous material at diagnosis, rather than after failure to respond to intravitreal antibiotics, may accelerate recovery from the infection. Early vitrectomy may improve vision recovery, patient well-being, reduce NHS and patient costs with less hospital visits,and assist in endeavours to reduce antibiotic usage.

    What will we do in this study?
    In order to measure the possible benefit of earlier surgery,we need to conduct a feasibility study of a multicentre randomised controlled trial to discover if the trial we are planning is possible in the reality of urgent care management of these people in current NHS environments.Participants will be randomly allocated to vitrectomy performed at an earlier stage of the condition,or later if needs be in accordance with standard care.

    What do our patients think about the study?
    We undertook a focus group with patients who had vitrectomy for endophthalmitis exploring their views and experiences.The consensus was the study was worthwhile.They advised us to approach study patients in an undisturbed environment with nursing support, giving them at least 48 hours to reflect on trial information plan patient advisory group meetings during the study to guide our research.

  • REC name

    West Midlands - Solihull Research Ethics Committee

  • REC reference

    20/WM/0264

  • Date of REC Opinion

    24 Nov 2020

  • REC opinion

    Further Information Favourable Opinion